ARCHIVES

Therapeutic Modalities Improve Patient Quality of Life In Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

December 30, 2011

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990

Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco

January 23, 1998

Bayh To Receive ACCC Annual Award

February 8, 1980

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

January 10, 1975